Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Neurology: Volume 77, Number 24, December 13, 2011
Faculty
S.Y.H. Kim, MD, PhD
Center for Bioethics and Social Sciences in Medicine
Department of Psychiatry
University of Michigan, Ann Arbor
H.M. Kim, ScD
Center for Statistical Consultation and Research
University of Michigan, Ann Arbor
D.S. Knopman, MD
Department of Neurology
Mayo Clinic
Rochester, MN
R. De Vries, PhD
Center for Bioethics and Social Sciences in Medicine
University of Michigan, Ann Arbor
L. Damschroder, MS
Health Services Research and Development
Ann Arbor VA Medical Center
Ann Arbor, MI
P.S. Appelbaum, MD
Division of Law, Ethics, and Psychiatry
Department of Psychiatry
Columbia University
New York State Psychiatric Institute
V. Guergueltcheva, MD, PhD
Department of Neurology
Medical University-Sofia
Sofia, Bulgaria
K. Peeters, MSc
Molecular Neurogenomics Group
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
J. Baets
Department of Neurology, University Hospital Antwerp
Antwerpen, Belgium
Department of Molecular Genetics, VIB, Antwerpen
Laboratory of Neurogenetics, Institute Born-Bunge
University of Antwerp, Antwerpen, Belgium
C. Ceuterick-de Groote, PhD
Laboratory of Ultrastructural Neuropathology
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
J.J. Martin, MD, PhD
Laboratory of Ultrastructural Neuropathology
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
A. Suls, PhD
Neurogenetics Group
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
E. De Vriendt
Molecular Neurogenomics Group
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
V. Mihaylova, MD, PhD
Department of Neurology
Medical University-Sofia
Sofia, Bulgaria
T. Chamova, MD
Department of Neurology
Medical University-Sofia
Sofia, Bulgaria
L. Almeida-Souza, MSc
Peripheral Neuropathies Group
VIB Department of Molecular Genetics
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
E. Ydens, MSc
Peripheral Neuropathies Group
VIB Department of Molecular Genetics
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
C. Tzekov, MD, PhD
Tokuda Hospital-Sofia
Sofia, Bulgaria
G. Hadjidekov, MD
Department of Radiology
University Hospital Lozenetz
Sofia, Bulgaria
M. Gospodinova, MD
Department of Internal Medicine
Medical University-Sofia
Sofia, Bulgaria
K. Storm, MSc
Department of Medical Genetics
University Hospital Antwerp
Antwerpen, Belgium
E. Reyniers, MSc
Department of Medical Genetics
University Hospital Antwerp
Antwerpen, Belgium
S. Bichev, MSc
National Genetics Laboratory
Department of Medical Chemistry and Biochemistry
Medical University-Sofia
Sofia, Bulgaria
P.F.M. van der Ven, PhD
Institute for Cell Biology
University of Bonn
Germany
D.O. Fürst, PhD
Institute for Cell Biology
University of Bonn
Germany
V. Mitev, MD, DSc
Molecular Medicine Center
Medical University-Sofia
Sofia, Bulgaria
H. Lochmüller, MD, PhD
Institute of Genetic Medicine
University of Newcastle
Newcastle, UK
V. Timmerman, PhD
Peripheral Neuropathies Group
VIB Department of Molecular Genetics
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
I. Tournev, MD, DSc
Department of Cognitive Science and Psychology
New Bulgarian University
Sofia, Bulgaria
P. De Jonghe
Department of Neurology, University Hospital Antwerp
Antwerpen, Belgium
Department of Molecular Genetics, VIB, Antwerpen
Laboratory of Neurogenetics, Institute Born-Bunge
University of Antwerp, Antwerpen, Belgium
A. Jordanova, PhD
Molecular Neurogenomics Group
Neurogenetics Laboratory
Institute Born-Bunge
University of Antwerp
Antwerpen, Belgium
Accredited by
American Academy of Neurology
Course Description
Upon completion of the article by Kim et al, the participant should be able to:
• Describe the range of support for surrogate consent in a variety of scenarios
• Discuss the effect of a deliberative democracy intervention on support for surrogate consent in Alzheimer disease
• Discuss the effect of an educational intervention on support for surrogate consent in Alzheimer disease
Upon completion of the article by Guergueltcheva et al, the participant should be able to:
• Discuss the function of filamin C
• Describe the clinical phenotype of patients with distal myopathy with upper limb predominance caused by filamin C haploinsufficiency
• Discuss the genetics of distal myopathy with upper limb predominance caused by filamin C haploinsufficiency
Activity Details
| Credit Types: | CME |
| Credit Amount: | 1.5 Credits |
| Release Date: | 2011-Dec-13 |
| Expiration Date: | 2013-Dec-13 |
| Registration Required: | Yes |
| Cost: | $624/yr |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
